Paul Goode, President & CEO, GlucoTrack, was recently a guest on Benzinga's All-Access. GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring ...

JACKSONVILLE, Fla., and NASHVILLE, Tenn. – Forcura, a workflow management company, and Medalogix, a clinical decision support company, have merged, creating what they say is a leading post-acute care ...

The MODD1 insulin pump. [Image from Modular Medical] Modular Medical (Nasdaq:MODD) announced today that it entered into definitive subscription agreements worth proceeds of approximately $12 million.

(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...

DETROIT, MICHIGAN - March 19, 2025 (NEWMEDIAWIRE) - Paul Goode, President & CEO, GlucoTrack (NASDAQ: GCTK), was recently a guest on Benzinga’s All-Access. GlucoTrack is a medical technology ...

RUTHERFORD, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...

Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...

Goode, PhD, President and Chief Executive Officer of Glucotrack (GCTK). “This ground-breaking study supports our approach to measuring glucose directly from the blood, rather than interstitial ...

RUTHERFORD, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for ...

You can read Aircraft For Sale: Today’s Top Pick at FLYINGMag.com daily. Today’s Top Pick is a 2023 Cirrus SF50 G2+ Vision Jet. If you possess the ratings, competence, currency, and budget ...

ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA ...